Literature DB >> 7859841

Helicobacter pylori seroepidemiology in risk groups.

A Quirós1, E Quirós, I González, M C Bernal, G Piedrola, M C Maroto.   

Abstract

Helicobacter pylori is associated with peptic ulcer and chronic active gastritis. The response to infection can be determined by measuring serum titers of anti-H. pylori antibodies. We compared antibody titers in 612 serum samples from 570 individuals considered at risk for H. pylori infection, 170 of them are control sera from 110 adults and 60 children with no gastric alterations. The study groups were 93 institutionalized mentally handicapped children, 40 heterosexual couples, 101 HIV-sero-positive patients, 86 patients with chronic renal failure and 40 individuals (20 adults and 20 children) with symptoms associated with gastritis or gastroduodenal ulcer disease. In the adult and child control groups, 33.5% and 11.6% of the individuals had circulating anti-H. pylori antibodies. Significantly more adults (80%) and children (75%) with gastric symptoms had detectable circulating antibody titers. Elevated titers were also found in institutionalized children and in adults with renal failure.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7859841     DOI: 10.1007/bf01719353

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  19 in total

1.  Elevated risk of Helicobacter pylori infection in submarine crews.

Authors:  I Hammermeister; G Janus; F Schamarowski; M Rudolf; E Jacobs; M Kist
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-01       Impact factor: 3.267

2.  Antibody titres to Campylobacter pylori after treatment for gastritis.

Authors:  D Vaira; J Holton; S R Cairns; M Falzon; A Polydorou; J F Dowsett; P R Salmon
Journal:  BMJ       Date:  1988-08-06

3.  Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons.

Authors:  C P Dooley; H Cohen; P L Fitzgibbons; M Bauer; M D Appleman; G I Perez-Perez; M J Blaser
Journal:  N Engl J Med       Date:  1989-12-07       Impact factor: 91.245

4.  Seroepidemiological study of the immune response to Campylobacter pylori in potential risk groups.

Authors:  A Reiff; E Jacobs; M Kist
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-07       Impact factor: 3.267

5.  Seroprevalence of Helicobacter pylori infections in Thailand.

Authors:  G I Perez-Perez; D N Taylor; L Bodhidatta; J Wongsrichanalai; W B Baze; B E Dunn; P D Echeverria; M J Blaser
Journal:  J Infect Dis       Date:  1990-06       Impact factor: 5.226

6.  Characterization of risk factors for Helicobacter pylori infection among men attending a sexually transmitted disease clinic: lack of evidence for sexual transmission.

Authors:  L B Polish; J M Douglas; A J Davidson; G I Perez-Perez; M J Blaser
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

7.  Gastric Helicobacter and upper gastrointestinal symptoms in chronic renal failure.

Authors:  K Ala-Kaila; P Vaajalahti; A L Karvonen; M Kokki
Journal:  Ann Med       Date:  1991-10       Impact factor: 4.709

8.  Dental plaque: a permanent reservoir of Helicobacter pylori?

Authors:  H G Desai; H H Gill; K Shankaran; P R Mehta; S R Prabhu
Journal:  Scand J Gastroenterol       Date:  1991-11       Impact factor: 2.423

9.  Isolation of Helicobacter pylori from saliva.

Authors:  D A Ferguson; C Li; N R Patel; W R Mayberry; D S Chi; E Thomas
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

10.  Campylobacter pylori antibodies in humans.

Authors:  G I Perez-Perez; B M Dworkin; J E Chodos; M J Blaser
Journal:  Ann Intern Med       Date:  1988-07-01       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.